Segall Bryant & Hamill LLC Reduces Holdings in HealthEquity, Inc. $HQY

Segall Bryant & Hamill LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 4.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 169,049 shares of the company’s stock after selling 8,759 shares during the period. Segall Bryant & Hamill LLC owned 0.20% of HealthEquity worth $14,127,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC purchased a new stake in shares of HealthEquity during the fourth quarter worth $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the fourth quarter worth about $28,000. Leonteq Securities AG boosted its position in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Torren Management LLC acquired a new position in HealthEquity during the fourth quarter worth about $40,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock worth $1,651,280 in the last 90 days. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on HQY shares. Citizens Jmp raised their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and increased their price target for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, July 25th. Finally, Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Price Performance

HealthEquity stock opened at $100.61 on Friday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $105.96. The stock has a market cap of $8.41 billion, a P/E ratio of 37.68, a PEG ratio of 1.69 and a beta of 0.21. The company has a 50-day moving average price of $91.74 and a 200 day moving average price of $85.12. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.